StockData
Theriva Biologics, Inc. logo

Theriva Biologics, Inc. (TOVX) stock

TOVXNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 4/30
$0.14+0.00 (+2.86%)

Close on Nov 18, 2026Market cap $6.61MP/E –Yield –

Theriva Biologics price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Theriva Biologics's price to sales ratio was 9.1× on Apr 29, 2011.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2011Apr 29, 20119.1×–

More Theriva Biologics figures

See a number that looks wrong?